ILONOV
Business purpose.
L'étude des effets des produits issus du muscle sur le diabète de type 1 et 2 ainsi que l'obésité et les complexités associés au diabète. L'exploitation de quelque manière que ce soit des résultats et études susvisées. Plus généralement la recherche scientifique liée au diabète de type 1 et 2.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Other research and experimental development on natural sciences and engineering (72.19Z)
- Sector
- Scientific research and development
- Headcount
- 3 to 5 employees
- Created
- 6 Nov 2020
- Share capital
- 61,250.00 EUR
- Registered with the trade register
- 17 Dec 2020
- Financial year end
- 31/12
- Establishments
- 1
Directors
- KARIM BOUZAKRI 51 years old, 06/1975 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- CEED INNOVATION via KARIM BOUZAKRI
Other companies at the same address
11 other company head offices are registered at this address.
- ASS INTERNAT OSTEOSYNTHESE DYNAMIQUE
- CTRE EUROPEEN D'ETUDE DU DIABETE
- POLE ACCOMPAGNEMENT PREVENTION SANTE ALSACE (POLE APSA)
- ASS FORMAT INFORM ENDOCRINOLOGIE ALSACE
- ASSOCIATION POUR L'EDUCATION THERAPEUTIQUE EN ALSACE
- OTC - FRANCE
- INSULIB
- CEED FORMATION
- CEED INNOVATION
- INSTITUT PREVENTION SANTE DIABETE GRAND EST
Establishments
Financial strength
Financial score
25 / 100 E
Confidence: low · computed on the financial year ended 31 Dec 2024
- Equity to assets (11.7 %)
- 6.9 out of 30
- EBITDA margin
- data missing, component not taken into account
- Liquidity (199.8 %)
- 9.0 out of 20
- Debt (683.2 %)
- 0.2 out of 15
- Revenue trend
- data missing, component not taken into account
formula fin-1.0
Legal score
92 / 100 A
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (6.0 years)
- 12.1 out of 20
- Accounts filed recently
- 20.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Revenue and earnings
Detailed accounts for this company are not reproduced here, but its main aggregates are public.
Revenue Net income
| Financial year | Revenue | Change | EBITDA | Net income |
|---|---|---|---|---|
| 31 Dec 2024 | 0 € | — | 0 € | 48,124 € |
| 31 Dec 2023 | 0 € | — | 0 € | 0 € |
| 31 Dec 2022 | 0 € | — | -109,489 € | -2,863 € |
| 31 Dec 2021 | 0 € | first year on record | -109,728 € | 3,828 € |
Aggregates published by the French Directorate General for Enterprise, computed from accounts filed with the commercial court.
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in August 2026
Legal notices
-
Amendment 31 Oct 2026
- Court :
- Greffe du Tribunal Judiciaire de Strasbourg
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20260210, annonce n 2720 · Proof of publication (PDF)
-
Filing of accounts 13 Jan 2026
- Court :
- Greffe du Tribunal Judiciaire de strasbourg
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20260007, annonce n 1412 · Proof of publication (PDF)
-
Amendment 9 Sep 2025
- Court :
- Greffe du Tribunal Judiciaire de Strasbourg
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20250172, annonce n 3419 · Proof of publication (PDF)
-
Amendment 2 Mar 2025
- Court :
- Greffe du Tribunal Judiciaire de Strasbourg
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20250043, annonce n 1494 · Proof of publication (PDF)
-
Filing of accounts 30 Jan 2025
- Court :
- Greffe du Tribunal Judiciaire de strasbourg
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20250021, annonce n 4903 · Proof of publication (PDF)
-
Filing of accounts 5 May 2024
- Court :
- Greffe du Tribunal Judiciaire de strasbourg
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20240088, annonce n 5675 · Proof of publication (PDF)
-
Filing of accounts 5 May 2024
- Court :
- Greffe du Tribunal Judiciaire de strasbourg
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20240088, annonce n 5676 · Proof of publication (PDF)
-
Amendment 11 Mar 2021
- Court :
- GREFFE DU TRIBUNAL D'INSTANCE DE STRASBOURG
- Amendment :
- Modification survenue sur le capital
BODACC B n 20210049, annonce n 2724 · Proof of publication (PDF)
-
Incorporation 14 Jan 2021
- Court :
- GREFFE DU TRIBUNAL D'INSTANCE DE STRASBOURG
BODACC A n 20210009, annonce n 1218 · Proof of publication (PDF)
Filings and annual accounts as PDF →
Filings and accounts
- Formality 30 Oct 2026
- Formality 5 Sep 2025
- Formality 27 Feb 2025
Change history
- Left: Directeur general 31 Oct 2026
- Appointed: Directeur general 9 Oct 2026
- Appointed: President de SAS 9 Oct 2026
- Share capital changed from 10,000 € to 40,000 € 3 Oct 2026
- Share capital changed from 61,250 € to 10,000 € 3 Oct 2026
- Share capital changed from 40,416.60 € to 61,250 € 2 Oct 2026
- Registered office: Boulevard René Leriche 67200 Strasbourg 2 Oct 2026
- Share capital: 40,416.60 € 2 Oct 2026
Frequently asked questions about ILONOV
- What is the SIREN number of ILONOV?
- The SIREN number of ILONOV is 892130303. Its intra-community VAT number is FR95892130303.
- Where is the head office of ILONOV?
- Head office address: BOULEVARD RENE LERICHE, 67200 STRASBOURG.
- When was ILONOV founded?
- ILONOV was founded on 6 Nov 2020.
- What does ILONOV do?
- Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
- Who runs ILONOV?
- The officer listed in the register is KARIM BOUZAKRI (President de SAS).
- What is the revenue of ILONOV?
- The latest published revenue is 0 €, for the 2024 financial year.
- How many employees does ILONOV have?
- The declared headcount is 3 to 5 employees. Insee data for 2024.
- Is ILONOV subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.